Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Freezing of Gait in PD
NCT06094309Unknown
- Sponsor
- Centro Hospitalar Universitário de Lisboa Central
- Start
- Jun 2024
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in Parkinson's disease (PD) comparing botulinum toxin with Placebo (2 arms). Primary endpoints: Variation Unified Parkinson's Disease Rating Scale Part III at 4 months, Timed Up & Go at 4 months and 1 more. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06094309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06094309.